Data / Form D filings / HDL THERAPEUTICS, INC.
HDL THERAPEUTICS, INC.: Form D filings
HDL THERAPEUTICS, INC., a biotechnology company in Vero Beach, FL, filed 7 Form D notices with the SEC between 2013 and 2023. The latest, on July 10, 2023, reports $1.3 million sold of a $7 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 601 21ST STREET, SUITE 300, Vero Beach, FL, 32960
- Phone
- (772) 453-2770
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1569047
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 10, 2023 | New notice | $7,000,000 | $1,270,074 | $5,729,926 | 15 | Jun 22, 2023 | sec.gov |
| Mar 4, 2021 | New notice | $50,000,000 | $3,355,237 | $46,644,763 | 31 | Feb 19, 2021 | sec.gov |
| Oct 3, 2019 | New notice | $3,000,070 | $3,000,019 | $51 | 34 | Sep 19, 2019 | sec.gov |
| May 10, 2017 | Amendment | $12,000,000 | $7,195,065 | $4,804,935 | 57 | Aug 5, 2016 | sec.gov |
| Sep 14, 2016 | New notice | $15,000,000 | $1,486,610 | $13,513,390 | 13 | Aug 5, 2016 | sec.gov |
| Dec 31, 2014 | New notice | $4,576,660 | $2,045,000 | $2,531,660 | 14 | May 2, 2014 | sec.gov |
| Feb 13, 2013 | New notice | $1,500,000 | $925,000 | $575,000 | 10 | Jan 31, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Matin | Executive Officer | |
| Gregg Sessa | Director | |
| Dane Andreeff | Director | |
| Bryan Brewer | Executive Officer |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Jul 10, 2023 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what HDL THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.